Rethinking molecular diagnostics
EFIRM (electric field induced release and measurement) is EZLife Bio's ecosystem for performing accurate genetic disease testing. EFIRM is robust, rapid, PCR-free,and DNA extraction free: electrochemical biosensors are effectively leveraged to streamline testing.
Only a drop (20 uL) of patient sample is needed to achieve nearly perfect detection of ctDNA targets in as little as 30 minutes. EZLife Bio is poised to reshape and radically simplify how genetic testing is done.Read more about the science behind EFIRM
EZLife Bio's platform offers a total solution for biomolecular detection. The Oasis Saliva Collector allows for rapid, non-invasive collection of saliva. The saliva can then be placed in the EFIRM96 Hybridization Device for rapid detection of biomarkers. Finally, this data can be uploaded to the EZLife EasyData platform for rapid data and reporting.Read more about our product
EFIRM: Versatility and power combined
Non-invasively monitoring of cancer biomarkers to track treatment response and recurrence
Unparalled ability to detect biomarkers, even in stage I and stage II cancer
The only liquid-biopsy platform to work on both blood and saliva
E.Coli and TB can be easily analyzed from a small amount of specimen
Allows easy measurement of hormone and health indicators
Versatile detection of a wide panel of novel markers
Capable of being deployed in limited resource settings
Easy to use platform for analytical chemistry and nanotechnology research
Our team of scientists and physicians is ready to work with you to explore new research and clinical applications to EFIRM.
Founded in 2016, EZLife Bio wants to rethink how molecular diagnostics is done with the EFIRM platform. We are dedicated to transforming the landscape of molecular testing. Our technology is published and credentialed, and we seek to back up our product assertions with rigorous and thorough attention to scientific data. We're hoping to
EFIRM is the world leader in being able to simultaneously detect DNA and protein based targets.
EZLife Bio Transforming Molecular Diagnostics